183 related articles for article (PubMed ID: 38546211)
1. Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.
Huang Y-J; Cheng T-L; Wang Y-T; Chen C-S; Leu Y-L; Chang C-S; Ho C-H; Chao S-W; Li C-T; Chuang C-H
J Virol; 2024 Apr; 98(4):e0125823. PubMed ID: 38546211
[TBL] [Abstract][Full Text] [Related]
2. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
3. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
Saqallah FG; Abbas MA; Wahab HA
Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
[TBL] [Abstract][Full Text] [Related]
5. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
Purohit P; Barik D; Agasti S; Panda M; Meher BR
J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
[TBL] [Abstract][Full Text] [Related]
8. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
[TBL] [Abstract][Full Text] [Related]
9. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
10. Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue.
Cheng J; Feng S; Zhang Y; Ding T; Jiang H; Zhang Z; Wang J; Wang X; Cheng M
Biochem Biophys Res Commun; 2022 Oct; 627():214-219. PubMed ID: 36058105
[TBL] [Abstract][Full Text] [Related]
11. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
[TBL] [Abstract][Full Text] [Related]
12. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.
Pelliccia S; Wu YH; Coluccia A; La Regina G; Tseng CK; Famiglini V; Masci D; Hiscott J; Lee JC; Silvestri R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1091-1101. PubMed ID: 28776445
[TBL] [Abstract][Full Text] [Related]
15. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.
Yang CC; Hsieh YC; Lee SJ; Wu SH; Liao CL; Tsao CH; Chao YS; Chern JH; Wu CP; Yueh A
Antimicrob Agents Chemother; 2011 Jan; 55(1):229-38. PubMed ID: 20937790
[TBL] [Abstract][Full Text] [Related]
16. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
Purohit P; Barik D; Dansana J; Meher BR
Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
[TBL] [Abstract][Full Text] [Related]
17. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
18. Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.
Tomlinson SM; Watowich SJ
Antiviral Res; 2011 Feb; 89(2):127-35. PubMed ID: 21185332
[TBL] [Abstract][Full Text] [Related]
19. (E)-Guggulsterone Inhibits Dengue Virus Replication by Upregulating Antiviral Interferon Responses through the Induction of Heme Oxygenase-1 Expression.
Chen WC; Wei CK; Hossen M; Hsu YC; Lee JC
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924157
[TBL] [Abstract][Full Text] [Related]
20. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
Gurusamy M; Abdul JF
Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
